• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NR4A2 在格雷夫斯病中的作用:调节 Th17/Treg。

A role of NR4A2 in Graves' disease: regulation of Th17/Treg.

机构信息

Department of Endocrinology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, PR China.

Department of Nuclear Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, PR China.

出版信息

Endocrine. 2024 Feb;83(2):432-441. doi: 10.1007/s12020-023-03490-9. Epub 2023 Aug 31.

DOI:10.1007/s12020-023-03490-9
PMID:37651006
Abstract

PURPOSE

This study aimed to explore the molecular pathogenesis of Graves' disease (GD).

METHODS

The gene expression profile in CD4 T cells from GD patients and healthy controls were analyzed through mRNA-sequencing. The expression of NR4A2 was determined by quantitative real-time PCR and western blot. The levels of Th17 and Treg were determined by flow cytometry. ELISA was employed to detect the levels of IL-10, IL-17A, IL-17F and IL-22.

RESULTS

In the CD4 T cells from GD patients, there were 128 up-regulated and 510 down-regulated genes. Subsequently, we focused on the role of nuclear receptor 4 group A member 2 (NR4A2) in GD. NR4A2 was lowly expressed in the CD4 T cells from GD patients. Its expression was negatively correlated with free triiodothyronine and tetraiodothyronine, but positively correlated with thyroid stimulating hormone. NR4A2 knockdown decreased the percentage of Treg cells, with a decreased IL-10 level. While its over-expression augmented the Treg differentiation, with an elevated IL-10 level. In addition, knockdown or over-expression of NR4A2 showed no significant influence on Th17 differentiation.

CONCLUSION

These results indicate that the low level of NR4A2 in GD patients may suppress Treg differentiation, but have no influence on Th17 differentiation, leading to the imbalance of Th17/Treg and contributing to the development of GD. Revealing the role of NR4A2 in GD provides a novel insight for the treatment of GD.

摘要

目的

本研究旨在探索格雷夫斯病(GD)的分子发病机制。

方法

通过 mRNA 测序分析 GD 患者和健康对照者 CD4 T 细胞中的基因表达谱。通过定量实时 PCR 和 Western blot 测定 NR4A2 的表达。通过流式细胞术测定 Th17 和 Treg 的水平。采用 ELISA 检测 IL-10、IL-17A、IL-17F 和 IL-22 的水平。

结果

在 GD 患者的 CD4 T 细胞中,有 128 个上调基因和 510 个下调基因。随后,我们重点研究了核受体 4 组 A 成员 2(NR4A2)在 GD 中的作用。NR4A2 在 GD 患者的 CD4 T 细胞中低表达。其表达与游离三碘甲状腺原氨酸和四碘甲状腺原氨酸呈负相关,与促甲状腺激素呈正相关。NR4A2 敲低降低了 Treg 细胞的百分比,IL-10 水平降低。而其过表达则增加了 Treg 分化,IL-10 水平升高。此外,NR4A2 的敲低或过表达对 Th17 分化没有显著影响。

结论

这些结果表明,GD 患者 NR4A2 水平低可能抑制 Treg 分化,但对 Th17 分化没有影响,导致 Th17/Treg 失衡,促进 GD 的发生。揭示 NR4A2 在 GD 中的作用为 GD 的治疗提供了新的思路。

相似文献

1
A role of NR4A2 in Graves' disease: regulation of Th17/Treg.NR4A2 在格雷夫斯病中的作用:调节 Th17/Treg。
Endocrine. 2024 Feb;83(2):432-441. doi: 10.1007/s12020-023-03490-9. Epub 2023 Aug 31.
2
[Role of Treg/Th17 cells and related cytokines in Graves' ophthalmopathy].[调节性T细胞/辅助性T细胞17及相关细胞因子在格雷夫斯眼病中的作用]
Nan Fang Yi Ke Da Xue Xue Bao. 2014 Dec;34(12):1809-13.
3
Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves' disease model.小鼠格雷夫斯病模型中调节性T细胞水平低且白细胞介素-17信使核糖核酸表达高。
J Endocrinol Invest. 2017 Apr;40(4):397-407. doi: 10.1007/s40618-016-0575-9. Epub 2016 Nov 7.
4
PTPN22 through the regulation of Th17/Treg balance acts as a potential target for the treatment of Graves' disease.PTPN22 通过调节 Th17/Treg 平衡,可作为 Graves 病治疗的潜在靶点。
Tissue Cell. 2024 Oct;90:102502. doi: 10.1016/j.tice.2024.102502. Epub 2024 Jul 27.
5
Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism.调节性 T 细胞而非辅助性 T 细胞 17 在 Graves 甲亢的动物模型中被调节。
Clin Exp Med. 2012 Mar;12(1):39-46. doi: 10.1007/s10238-011-0137-6. Epub 2011 May 5.
6
Effect of IL-21 on the Balance of Th17 Cells/Treg Cells in the Pathogenesis of Graves' Disease.白细胞介素-21 对格雷夫斯病发病机制中 Th17 细胞/Treg 细胞平衡的影响。
Endocr Res. 2019 Nov;44(4):138-147. doi: 10.1080/07435800.2019.1600535. Epub 2019 May 4.
7
Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls.自身免疫性甲状腺疾病患者和健康对照者的调节性B细胞和T细胞反应。
Dan Med J. 2016 Feb;63(2).
8
Imbalance of Th17/Treg in Different Subtypes of Autoimmune Thyroid Diseases.自身免疫性甲状腺疾病不同亚型中Th17/Treg失衡
Cell Physiol Biochem. 2016;40(1-2):245-252. doi: 10.1159/000452541. Epub 2016 Nov 18.
9
Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves' Disease.调节性 T 细胞和 TCR 扩增减少与 Graves 病的长期存在有关。
Front Endocrinol (Lausanne). 2021 Apr 12;12:632492. doi: 10.3389/fendo.2021.632492. eCollection 2021.
10
Increased Circulating Th17 but Decreased CD4Foxp3 Treg and CD19CD1dCD5 Breg Subsets in New-Onset Graves' Disease.在新发 Graves 病患者中,循环 Th17 细胞增加,而 CD4Foxp3 Treg 和 CD19CD1dCD5 Breg 亚群减少。
Biomed Res Int. 2017;2017:8431838. doi: 10.1155/2017/8431838. Epub 2017 Nov 13.

引用本文的文献

1
Global research landscape and emerging trends in Graves' disease: A bibliometric analysis.格雷夫斯病的全球研究格局和新兴趋势:文献计量分析。
Medicine (Baltimore). 2024 Jun 14;103(24):e37963. doi: 10.1097/MD.0000000000037963.
2
The Promotion of Humoral Immune Responses in Humans via SOCS1-Mediated Th2-Bias Following SARS-CoV-2 Vaccination.SARS-CoV-2疫苗接种后通过SOCS1介导的Th2偏向促进人类体液免疫反应
Vaccines (Basel). 2023 Nov 20;11(11):1730. doi: 10.3390/vaccines11111730.

本文引用的文献

1
Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.大样本 Graves 病甲亢抗甲状腺药物治疗的长期随访结果。
Eur Thyroid J. 2023 Mar 17;12(2). doi: 10.1530/ETJ-22-0226. Print 2023 Apr 1.
2
Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease.全面免疫表型分析揭示了 Th17 细胞在格雷夫斯病中的病理作用。
Sci Rep. 2022 Oct 7;12(1):16880. doi: 10.1038/s41598-022-19556-z.
3
Comparison Between Nr4a Transcription Factor Regulation and Function in Lymphoid and Tumor Treg Cells.
Nr4a 转录因子在淋巴和肿瘤 Treg 细胞中的调控和功能比较。
Front Immunol. 2022 Apr 19;13:866339. doi: 10.3389/fimmu.2022.866339. eCollection 2022.
4
Absolute reduction in peripheral regulatory T cells in patients with Graves' disease and post-treatment recovery.格雷夫斯病患者外周调节性T细胞的绝对减少及治疗后的恢复
Mol Immunol. 2022 Apr;144:49-57. doi: 10.1016/j.molimm.2022.02.004. Epub 2022 Feb 18.
5
Genetics, Epigenetics, Cellular Immunology, and Gut Microbiota: Emerging Links With Graves' Disease.遗传学、表观遗传学、细胞免疫学与肠道微生物群:与格雷夫斯病的新联系
Front Cell Dev Biol. 2022 Jan 4;9:794912. doi: 10.3389/fcell.2021.794912. eCollection 2021.
6
Nurr1 performs its anti-inflammatory function by regulating RasGRP1 expression in neuro-inflammation.Nurr1 通过调节神经炎症中的 RasGRP1 表达来发挥其抗炎功能。
Sci Rep. 2020 Jul 1;10(1):10755. doi: 10.1038/s41598-020-67549-7.
7
Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death.NR4A2(Nurr1)的分子机制研究:神经炎症和神经元细胞死亡的神经保护治疗的新兴靶点
Mol Neurobiol. 2019 Aug;56(8):5799-5814. doi: 10.1007/s12035-019-1487-4. Epub 2019 Jan 25.
8
Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance.抑制 Nr4a 受体通过打破 Treg 介导的免疫耐受增强抗肿瘤免疫。
Cancer Res. 2018 Jun 1;78(11):3027-3040. doi: 10.1158/0008-5472.CAN-17-3102. Epub 2018 Mar 20.
9
NR4A2 protects cardiomyocytes against myocardial infarction injury by promoting autophagy.NR4A2通过促进自噬保护心肌细胞免受心肌梗死损伤。
Cell Death Discov. 2018 Feb 15;4:27. doi: 10.1038/s41420-017-0011-8. eCollection 2018 Dec.
10
Increased Circulating Th17 but Decreased CD4Foxp3 Treg and CD19CD1dCD5 Breg Subsets in New-Onset Graves' Disease.在新发 Graves 病患者中,循环 Th17 细胞增加,而 CD4Foxp3 Treg 和 CD19CD1dCD5 Breg 亚群减少。
Biomed Res Int. 2017;2017:8431838. doi: 10.1155/2017/8431838. Epub 2017 Nov 13.